Fermenta Biotech Limited (BOM:506414)
320.60
-8.10 (-2.46%)
At close: Jun 16, 2026
Fermenta Biotech Revenue
In the fiscal year ending March 31, 2026, Fermenta Biotech had annual revenue of 5.25B INR with 11.92% growth. Fermenta Biotech had revenue of 1.22B in the quarter ending March 31, 2026, a decrease of -13.06%.
Revenue
5.25B
Revenue Growth
+11.92%
P/S Ratio
1.80
Revenue / Employee
8.67M
Employees
606
Market Cap
9.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.25B | 559.52M | 11.92% |
| Mar 31, 2025 | 4.69B | 1.34B | 39.87% |
| Mar 31, 2024 | 3.36B | -142.79M | -4.08% |
| Mar 31, 2023 | 3.50B | -485.75M | -12.19% |
| Mar 31, 2022 | 3.99B | 212.27M | 5.63% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 8.57B |
| Anuh Pharma | 7.72B |
| Lincoln Pharmaceuticals | 7.04B |
| Sudarshan Pharma Industries | 7.03B |
| Kopran | 6.81B |
| Wanbury | 6.50B |
| Fredun Pharmaceuticals | 6.35B |
| Syncom Formulations (India) | 4.89B |